Clinical Trial Update: Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents [Phase 3]

View source ↗

Summary

Phase 3 discontinuation study of citalopram in depressed adolescents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Major Depression | Phase 3 | Status: WITHDRAWN